---
title: "Lakewood-Amedex Soars Over 53% Amid Board Appointment"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/284904614.md"
description: "Lakewood-Amedex Biotherapeutics（LABT.US）现价 $4.088，当日 +53.68%，盘中震荡拉升，市值暂无数据。公司聚焦生物治疗领域，股价大涨与 Joseph Tucker 博士加入董事会相关。近期无其他重大消息，市场偏向短线资金驱动。"
datetime: "2026-05-01T13:39:56.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/284904614.md)
  - [en](https://longbridge.com/en/news/284904614.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/284904614.md)
---

# Lakewood-Amedex Soars Over 53% Amid Board Appointment

Lakewood-Amedex Biotherapeutics (LABT.US) trades at $4.088, up **+53.68%** intraday, with no disclosed market cap.

The company operates in the biotherapeutics sector. The sharp rise follows the appointment of Dr. Joseph Tucker to the board. No further significant news; momentum likely driven by speculative trading.

### Related Stocks

- [LABT.US](https://longbridge.com/en/quote/LABT.US.md)

## Related News & Research

- [AMETEK, Inc. $AME Stock Holdings Trimmed by Bank Julius Baer & Co. Ltd Zurich](https://longbridge.com/en/news/286381855.md)
- [Hyperliquid Faces Fresh Solana Threat As Toly Backs New Perp DEX](https://longbridge.com/en/news/286852024.md)
- [Alaunos Reports Preclinical Aln1003 Data Showing Effects On Insulin-Resistance-Related Biomarkers And Liver Histology In Diet-Induced Obesity Models](https://longbridge.com/en/news/286776760.md)
- [Nanjing Leads Biolabs Wins Phase III Green Light for Key Cancer Drug Opamtistomig](https://longbridge.com/en/news/286828874.md)
- [Island Pharmaceuticals Strengthens Biodefence Engagement for Galidesivir Advancement](https://longbridge.com/en/news/286834766.md)